CAG
RecoveryNot a defined single compoundAlso known as: CAG peptide, Collagen-derived peptide, Gly-Hyp-Pro related peptide
CAG is not a standardized research-peptide designation. The letters are sometimes used loosely for collagen- or cartilage-related short sequences (for example the tripeptide Cys-Ala-Gly), but no single, vendor-sold research compound is reliably identified by "CAG," and no peer-reviewed pharmacology exists under that name.
Overview
At A Glance
What "CAG" refers to…
Mechanism of Action
What "CAG" refers to
There is no consensus molecule behind the label "CAG." It is an ambiguous shorthand rather than a characterized research peptide, so this page does not assign it a fixed amino-acid sequence, molecular weight, mechanism, or dosing protocol - doing so would imply a precision that the evidence does not support.
If you arrived here looking for a specific compound:
- For a defined cartilage bioregulator, see Cartalax (Ala-Glu-Asp-Leu, AEDL).
- For collagen/skin support, see GHK-Cu (the copper tripeptide with the best cosmetic evidence).
- For general connective-tissue recovery, see BPC-157 and TB-500.
Research Use Only. We keep this entry deliberately empty of specifics because inventing a sequence or protocol for an undefined designation would be inaccurate.
Overview
CAG is not a standardized research-peptide designation. The letters are sometimes used loosely for collagen- or cartilage-related short sequences (for example the tripeptide Cys-Ala-Gly), but no single, vendor-sold research compound is reliably identified by "CAG," and no peer-reviewed pharmacology exists under that name. If you are looking for a defined cartilage-targeting peptide, see Cartalax (the Ala-Glu-Asp-Leu / AEDL Khavinson bioregulator).
Chemical Information
IUPAC Name
Not yet available
CAS Number
Not yet available
Molecular Formula
Not yet available
Molecular Mass
Not yet available
Chemical data is being compiled for this compound.
Dosing & Protocols
Unlock Dosing Protocols
Free account gets you:
- View beginner, intermediate & advanced protocols
- See weight-based dosing calculations
- Access cycle length & frequency data
2,800+ researchers already in
Research
Unlock Research Data
Free account gets you:
- Browse PubMed study summaries
- See clinical trial phases & results
- Access mechanism of action details
2,800+ researchers already in
Interactions
Interaction and contraindication data is being compiled for CAG. Check back soon.
General Safety Note
Always consult a qualified healthcare professional before combining research compounds. Interactions may exist that are not yet documented.
$59.00
up to $99.00
$9.9000
1
2
vial
| Vendor | Product | Form | Qty | Price | $/mg | Coupon | |
|---|---|---|---|---|---|---|---|
 |
CAG 5mg | vial | 1 vial● In Stock | $59.00BEST | $11.800 | — | |
|
|
CAG 10mg | vial | 1 vial● In Stock | $99.00VALUE | $9.900 | — |
Tracking since Apr 22, 2026 · 2 data points
Vendors Selling CAG
How we score these vendors
Every supplier above is graded 0–100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank.
Related Compounds
View AllARA-290
RecoveryPhase 2ARA-290, also known as Cibinetide or pHBSP (Helix B Surface Peptide), is an 11-amino-acid peptide — QEQLERALNSS — designed to mimic a specific region of the tissue-protective surface of erythropoietin (EPO) without activating the classical hematopoietic EPO receptor that drives red blood cell production.
BPC-157/TB-500 Blend
RecoveryPreclinicalCombined healing peptide blend.
Bronchogen
RecoveryPreclinicalBronchogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cardiogen
RecoveryPreclinicalCardiogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cartalax
RecoveryPreclinicalCartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St.
Chonluten
RecoveryPreclinicalChonluten is a bioregulator preparation originating from Vladimir Khavinson's St.
View Full Dosage Guide →
Protocols, calculator & safety for CAG
Related Articles
All PostsBromantane (Ladasten): What It Is and What the Research Shows
A grounded compound reference on bromantane (Ladasten, ADK-709): an adamantane-derivative actoprotector that raises dopamine synthesis via tyrosine hydroxylase, combines mild stimulant and anxiolytic effects, is approved only in Russia for asthenia, and remains a research chemical in the US. Covers verified mechanism, human trials, study doses, community practice, and safety.
7/1/2026Aquasome Nanotechnology and Oral Peptides: The Mechanism, the Research, and the 10 Compounds It Actually Works For
how aquasome 3-layer nano-encapsulation lets peptides like retatrutide, bpc-157, and tb-500 survive the gut. pubmed-backed deep dive on the 10 compounds it works for.
5/20/2026Retatrutide Protocol Guide: What the Phase 2 Trial Actually Showed
An education-first walkthrough of retatrutide (LY3437943), the triple GLP-1/GIP/glucagon agonist. Covers the Phase 2 NEJM trial data at 24 and 48 weeks, the trial titration schedule, side effects, reconstitution, and honest sourcing. Research-use-only, not FDA-approved, not medical advice.
5/19/2026Research Score
0 PubMed studies
Quality Indicators
Data Completeness
63%Quick Facts
Half-Life
Unknown
Administration
Subcutaneous, Intraarticular
Trial Phase
Not a defined single compound
Safety Profile
Common Side Effects
- • Limited adverse event data available
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Frequently Asked Questions
Is CAG a real peptide?
What should I use instead?
Depends on your goal: Cartalax (AEDL) for cartilage, GHK-Cu for skin/collagen, BPC-157 and TB-500 for connective-tissue recovery. Each has a defined identity and its own page.
Research Tools
Related Compounds
View AllARA-290
RecoveryPhase 2ARA-290, also known as Cibinetide or pHBSP (Helix B Surface Peptide), is an 11-amino-acid peptide — QEQLERALNSS — designed to mimic a specific region of the tissue-protective surface of erythropoietin (EPO) without activating the classical hematopoietic EPO receptor that drives red blood cell production.
BPC-157/TB-500 Blend
RecoveryPreclinicalCombined healing peptide blend.
Bronchogen
RecoveryPreclinicalBronchogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cardiogen
RecoveryPreclinicalCardiogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cartalax
RecoveryPreclinicalCartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St.
Chonluten
RecoveryPreclinicalChonluten is a bioregulator preparation originating from Vladimir Khavinson's St.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Reconstitution math, concentration charts, half-lives, and vendor trust tiers. The reference we wish we had on day one.